IRIS - Res&Arch Institutional Research Information System - Research & Archive

VEDOVATI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.336
AS - Asia 1.988
EU - Europa 1.706
SA - Sud America 463
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.284
SG - Singapore 978
BR - Brasile 390
IT - Italia 378
IE - Irlanda 376
CN - Cina 307
HK - Hong Kong 298
RU - Federazione Russa 263
VN - Vietnam 195
DE - Germania 134
UA - Ucraina 121
SE - Svezia 109
FI - Finlandia 99
GB - Regno Unito 65
KR - Corea 54
FR - Francia 51
TR - Turchia 29
AT - Austria 25
CA - Canada 24
IN - India 23
MX - Messico 23
PL - Polonia 20
AR - Argentina 19
BD - Bangladesh 16
EC - Ecuador 15
UZ - Uzbekistan 14
BE - Belgio 12
IQ - Iraq 12
JP - Giappone 10
ES - Italia 8
ID - Indonesia 8
PY - Paraguay 8
VE - Venezuela 8
ZA - Sudafrica 8
CH - Svizzera 7
CO - Colombia 7
LT - Lituania 7
MA - Marocco 7
NL - Olanda 7
PE - Perù 7
PK - Pakistan 7
BG - Bulgaria 5
CZ - Repubblica Ceca 5
EG - Egitto 5
JO - Giordania 5
TN - Tunisia 5
CL - Cile 4
DZ - Algeria 4
GR - Grecia 4
LB - Libano 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AZ - Azerbaigian 3
IL - Israele 3
KW - Kuwait 3
OM - Oman 3
RO - Romania 3
UY - Uruguay 3
DK - Danimarca 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.533
Salva come PNG Salva come JPEG
Città #
Singapore 650
Dublin 376
Chandler 325
Hong Kong 297
San Mateo 176
Perugia 128
Boardman 125
Altamura 121
Santa Clara 117
Ashburn 105
Moscow 101
Ann Arbor 91
Medford 91
Princeton 90
Lawrence 89
Dong Ket 86
Beijing 74
Jacksonville 61
Munich 57
Los Angeles 55
Seoul 54
Wilmington 48
Andover 46
Ho Chi Minh City 46
Redmond 36
São Paulo 36
New York 34
Des Moines 30
Hanoi 28
The Dalles 27
Turku 23
Nuremberg 21
Piscataway 21
Redwood City 19
Rio de Janeiro 19
Saint Petersburg 19
Helsinki 17
Izmir 15
Chennai 14
Norwalk 14
San Paolo di Civitate 14
Woodbridge 14
Amelia 13
London 13
Brooklyn 12
Brussels 12
Rome 12
Columbus 11
Orem 11
Shanghai 11
Belo Horizonte 10
Stockholm 10
Tokyo 10
Warsaw 10
Boston 9
Dallas 9
Frankfurt am Main 9
Houston 9
Montreal 9
Vienna 8
Brasília 7
Campinas 7
Denver 7
Falkenstein 7
Manchester 7
Poplar 7
Tashkent 7
Curitiba 6
Hefei 6
Johannesburg 6
Lappeenranta 6
Mexico City 6
Toronto 6
Atlanta 5
Guarulhos 5
Mumbai 5
Porto Alegre 5
Quito 5
Salvador 5
Sorocaba 5
Tianjin 5
Americana 4
Amman 4
Ankara 4
Baghdad 4
Bologna 4
Campo Grande 4
Chicago 4
Chongqing 4
Da Nang 4
Falls Church 4
Fortaleza 4
Gainesville 4
Goiânia 4
Guangzhou 4
Haiphong 4
Lausanne 4
Lima 4
Milan 4
Ottawa 4
Totale 4.199
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 133
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 129
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 126
Aspirin for preventing the recurrence of venous thromboembolism. 109
Thrombophilia and cerebral vein thrombosis 101
Antecolic or Retrocolic Alimentary Limb in Laparoscopic Roux-en-Y Gastric Bypass? A Meta-Analysis 99
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 98
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 91
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 90
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 89
A new strategy for anticoagulation: The factor XI inhibitors 87
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 85
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 85
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 84
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 84
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 81
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 81
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 81
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 80
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 79
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 78
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 77
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 76
Combined oral anticoagulants and antiplatelets: benefits and risks. 75
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 75
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 75
Beyond the guidelines: Novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism 75
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 74
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 74
Carotid plaque detection improves the predictve value of CHA 2 DS 2 -VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 73
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 72
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation 72
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 71
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 71
Thrombotic risk after a major bleeding during anticoagulation: A clinical case 71
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 71
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 71
[2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism: what's new?] 71
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 70
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 69
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 69
Intra-abdominal drainage after pancreatic resection: Is it really necessary? A meta-analysis of short-term outcomes 68
Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight 66
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 66
Accuracy of Physicians in Differentiating Type 1 and Type 2 Myocardial Infarction Based on Clinical Information 66
Reply 65
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 64
A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer 63
Patients with acute pulmonary embolism at intermediate risk for death: Can we further stratify? 63
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 62
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 61
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 61
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants 60
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study 58
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 57
Predictors of new onset atrial fibrillation after myocardial infarction 57
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 57
Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. 56
To drain or not to drain elective uncomplicated laparoscopic cholecystectomy? A systematic review and meta-analysis 55
One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study 55
Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. 54
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 53
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 53
MDCT-detected embolic burden and clinical outcome in patients with acute pulmonary embolism 53
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 53
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis 51
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study 51
[Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment] 50
Prognostic value of troponins in acutepulmonary embolism: a meta-analysis. 50
Old and new oral anticoagulants forvenous thromboembolism and atrial fibrillation: A review of the literature. 50
Multidetectorcomputed tomography for acute pulmonary embolism: diagnosis and riskstratification in a single test. 49
To drain or not to drain extraperitoneal colorectal anastomosis? A systematic review and meta-analysis. 49
Efficacy and safety of direct oral anticoagulants after pulmonary embolism: A meta-analysis 49
Prognostic value of the CHA2DS2Vasc score in patients experiencing a myocardial infarction 48
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 48
Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. 47
Novel oral anticoagulants for patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 47
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study 46
Right ventricle dysfunction in patients with pulmonary embolism. 46
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 46
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study 46
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 46
[A new anticoagulant strategy: the factor XI inhibitors] 46
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis 45
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 45
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE 45
Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. 44
Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: A case report 44
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism 43
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management 43
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 42
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 41
[Anticoagulation therapy during pulmonary embolism follow-up in clinical practice] 41
Novel oral anticoagulants in patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 41
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 41
Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study 41
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. 40
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 37
Patients with Atrial Fibrillation receiving NOACs: The boundary between appropriate and inappropriate dose 37
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 36
Totale 6.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 28 28 14 29 13 25 89
2021/2022693 7 126 8 20 32 4 8 206 24 59 91 108
2022/20231.272 94 293 18 71 76 121 0 45 493 5 33 23
2023/2024496 26 54 29 9 6 1 107 3 41 35 104 81
2024/20251.594 18 130 45 89 238 59 76 106 340 103 260 130
2025/20261.731 231 191 181 467 423 238 0 0 0 0 0 0
Totale 6.772